FDA Safety Communication Does Not Impact BD Syringes

Company Committed to Support U.S. Health Care Needs FRANKLIN LAKES, N.J., Nov. 30, 2023 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the U.S. Food and Drug Administration (FDA)…